搜索筛选:
搜索耗时0.6765秒,为你在为你在102,267,441篇论文里面共找到 11 篇相符的论文内容
发布年度:
[期刊论文] 作者：Theodosios D Filippatos,Moses,
来源：世界肝病学杂志：英文版（电子版） 年份：2010
Non-alcoholic fatty liver disease (NAFLD) includes simple steatosis, a benign condition, and non-alcoholic steatohepatitis, a condition that beyond TG accumulat...
[期刊论文] 作者：Theodosios D Filippatos,Moses,
来源：世界糖尿病杂志：英文版（电子版） 年份：2010
Drug combinations that include antiobesity drugs(such as orlistat and sibutramine) and target cardiovascular disease(CVD) risk factors may be a good approach to...
[期刊论文] 作者：Theodosios D Filippatos,Moses,
来源：世界糖尿病杂志：英文版（电子版） 年份：2013
Glucagon-like peptide-1(GLP-1)receptor agonists result in greater improvements in glycemic control than placebo and promote weight loss with minimal hypoglycemi...
[期刊论文] 作者：Theodosios D Filippatos,Moses,
来源：世界心脏病学杂志：英文版（电子版） 年份：2013
Several epidemiological studies have clearly shown that low plasma levels of high density lipoprotein cholesterol (HDL-C) represent a cardiovascular disease (CV...
[期刊论文] 作者：Theodosios D Filippatos,Moses,
来源：世界心脏病学杂志：英文版（电子版） 年份：2013
The present review analyses the mechanisms relating heart failure and hyponatremia,describes the association of hyponatremia with the progress of disease and mo...
[期刊论文] 作者：Theodosios D Filippatos,Moses,
来源：世界肝病学杂志：英文版（电子版） 年份：2011
Non-alcoholic fatty liver disease (NAFLD) encompasses a histological spectrum ranging from simple steatosis to steatohepatitis,advanced fibrosis and inflammator...
[期刊论文] 作者：Theodosios D Filippatos,Sebast,
来源：世界糖尿病杂志：英文版（电子版） 年份：2017
Proprotein convertase subtilisin/kexin type 9(PCSK9) plays a paramount role in the degradation of lowdensity lipoprotein(LDL) receptors(LDLR) on the hepatic cel...
[期刊论文] 作者：Theodosios D Filippatos,Moses S Elisaf,,
来源：World Journal of Hepatology 年份：2010
Non-alcoholic fatty liver disease (NAFLD) includes simple steatosis, a benign condition, and non-alcoholic steatohepatitis, a condition that beyond TG accumulat...
[期刊论文] 作者：Theodosios D Filippatos,Moses S Elisaf,,
来源：World Journal of Diabetes 年份：2013
Glucagon-like peptide-1(GLP-1)receptor agonists result in greater improvements in glycemic control than placebo and promote weight loss with minimal hypoglycemi...
[期刊论文] 作者：Theodosios D Filippatos,Moses S Elisaf,,
来源：World Journal of Hepatology 年份：2011
Non-alcoholic fatty liver disease (NAFLD) encompasses a histological spectrum ranging from simple steatosis to steatohepatitis,advanced fibrosis and inflammator...
[期刊论文] 作者：Theodosios D Filippatos,Sebastian Filippas-Ntekouan,Eleni Pappa,Thalia Panagiotopoulou,Vasilios Tsimihodimos,
来源：World Journal of Diabetes 年份：2017
Proprotein convertase subtilisin/kexin type 9(PCSK9) plays a paramount role in the degradation of lowdensity lipoprotein(LDL) receptors(LDLR) on the hepatic cel...
相关搜索：
